| View |
|
DR-XY44067
|
Lactoferrin + D-Alpha Tocopheryl Acetate + Zinc
|
None
|
100mg/ 8 I.U./ 2.5mg
|
Capsule
|
-
|
Amherst Laboratories, Inc.
|
Philippines
|
-
|
17 January 2020
|
14 January 2025
|
| View |
|
DR-XY44073
|
None
|
D-Alpha Tocopheryl Acetate (Vitamin E)
|
400 IU
|
Softgel Capsule
|
-
|
Now Foods
|
U.S.A.
|
-
|
16 September 2019
|
22 January 2025
|
| View |
DR-XY44078_PI_01.pdf
|
DR-XY44078
|
LINEZOLID
|
AXAZOLID
|
2mg/ mL (600 mg/300 mL)
|
Solution for IV infusion
|
Antibacterial
|
Axa Parenterals Ltd.
|
India
|
Renewal
|
12 February 2024
|
20 May 2029
|
| View |
|
DR-XY44081
|
Mometasone Furoate
|
Momeflo
|
1mg/g (0.1% w/w)
|
Cream
|
-
|
Lloyd laboratories, Inc.
|
Philippines
|
-
|
28 September 2020
|
15 July 2025
|
| View |
|
DR-XY44089
|
Isotretinoin
|
Acnoin-10
|
10 mg
|
Softgel Capsule
|
Anti-Acne
|
Renown Pharmaceuticals Pvt. Ltd.
|
India
|
Renewal
|
13 October 2024
|
29 January 2030
|
| View |
|
DR-XY44096
|
Pregabalin
|
None
|
75mg
|
Capsule
|
Anti-epileptic
|
Drugmaker's Laboratories Inc.
|
Philippines
|
Automatic Renewal
|
28 February 2022
|
23 January 2027
|
| View |
|
DR-XY44097
|
Docetaxel (As Trihydrate)
|
Anmotic
|
40 mg/mL
|
Concentrate Solution for IV Infusion
|
Antineoplastic
|
Adley Formulations
|
India
|
Initial
|
21 January 2022
|
23 January 2025
|
| View |
|
DR-XY44102
|
Aspirin + Rosuvastatin (as calcium)
|
Rosuprin
|
80mg/10mg
|
Capsule
|
Lipid Modifying Agents
|
Ajanta Pharma Limited
|
India
|
Initial (from Monitored Release status) Re-issuance
|
24 May 2022
|
26 January 2025
|
| View |
|
DR-XY44103
|
Aspirin + Rosuvastatin (as calcium)
|
Rosuprin
|
80mg/20mg
|
Capsule
|
Lipid Modifying Agent
|
Ajanta Pharma Limited
|
India
|
Initial (from Monitored Release status) Re-issuance
|
10 May 2022
|
26 January 2025
|
| View |
|
DR-XY44104
|
Cefuroxime (As Sodium)
|
Zicef
|
750mg
|
Powder For Injection (IM/IV)
|
-
|
China National (Group) Corporation of Medicines, Guorui Pharmaceutical Co., Ltd.
|
China
|
-
|
29 January 2020
|
26 January 2025
|
| View |
|
DR-XY44105
|
Salbutamol (as sulfate)
|
I-Breath
|
100 mcg
|
Pressurized Metered Dose for Inhalation
|
-
|
The ACME Laboratories Inc.
|
Bangladesh
|
-
|
26 December 2019
|
29 January 2025
|
| View |
|
DR-XY44108
|
Atenolol
|
Unbranded
|
50 mg
|
Film-Coated Tablet
|
Beta Adrenoceptor Blocker
|
Lloyd Laboratories, Inc.
|
Philippines
|
Renewal
|
24 September 2024
|
23 January 2030
|
| View |
|
DR-XY44110
|
Atenolol
|
Tenol
|
50 mg
|
Film-Coated Tablet
|
Beta Adrenoceptor Blocker
|
Lloyd Laboratories, Inc.
|
Philippines
|
Renewal
|
27 October 2024
|
23 January 2030
|
| View |
|
DR-XY44113
|
Amitriptyline Hydrochloride
|
Tripmed
|
25 mg
|
Film-Coated Tablet
|
Antidepressant
|
Lloyd Laboratories, Inc.
|
Philippines
|
Renewal
|
09 October 2024
|
23 January 2030
|
| View |
|
DR-XY44116
|
Telmisartan
|
Unbranded
|
40 mg
|
Tablet
|
Angiotensin II Receptor Blocker
|
Hizon Laboratories, Inc.
|
Philippines
|
Renewal
|
09 October 2024
|
23 January 2030
|
| View |
|
DR-XY44120
|
Ceftriaxone (As Sodium)
|
Ceftrirex
|
1 g
|
Powder For Solution For Injection (Im/Iv)
|
-
|
Jiangxi Xier Kangtai Pharmaceutical Co., Ltd.
|
China
|
-
|
08 October 2019
|
28 January 2025
|
| View |
|
DR-XY44123
|
Desloratadine
|
Allergon
|
5 mg
|
Film-Coated Tablet
|
Antihistamine
|
Hainan Poly Pharmaceutical Co., Ltd.
|
China
|
Automatic Renewal
|
02 March 2023
|
02 February 2028
|
| View |
|
DR-XY44129
|
Betamethasone (as dipropionate)
|
Unbranded
|
500 mcg/g (0.05%)
|
Cream
|
Corticosteroid
|
Lloyd Laboratories, Inc.
|
Philippines
|
Renewal
|
21 October 2024
|
02 February 2030
|
| View |
|
DR-XY44130
|
DONEPEZIL (as hydrochloride)
|
SERVONEX
|
5 mg
|
Film-Coated Tablet
|
CHOLINESTERASE INHIBITOR
|
Kusum Healthcare Private Limited
|
India
|
Automatic Renewal
|
31 January 2022
|
02 February 2027
|
| View |
|
DR-XY44132
|
Co-Amoxiclav
|
Comolav
|
228.5mg/ 5mL
|
Powder For Suspension
|
Antibacterial
|
Lloyd Laboratories, Inc.
|
Philippines
|
Renewal
|
12 October 2024
|
27 January 2030
|